ligands acting on targets

PGE1 is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. PGE1 inhibits platelet aggregation (IC|50|= 40 nM) and increases vasodilation.13,14-dihydro-16,16-difluoro PGE1 is a biologically active metabolite

PGE1 is produced by the metabolism of dihomo-γ-linolenic acid (DGLA) by the cyclooxygenase pathway. PGE1 inhibits platelet aggregation (IC|50|= 40 nM) and increases vasodilation.13,14-dihydro-16,16-difluoro PGE1 is a biologically active metabolite

13,14-dihydro-15-keto Prostaglandin A2 is a product of the non-enzymatic dehydration of 13,14-dihydro-15-keto PGE|2|. It is further broken down into bicyclo PGE|2|, which acts as a biomarker for PGE|2|synthesis.

13,14-dihydro-15-keto Prostaglandin A2 is a product of the non-enzymatic dehydration of 13,14-dihydro-15-keto PGE|2|. It is further broken down into bicyclo PGE|2|, which acts as a biomarker for PGE|2|synthesis.

The theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. An inhibitor of ADP-induced platelet aggregation in humans with an IC|50|value of 320 ng/ml, about 1/10 as potent as

The theoretical D-series metabolite of dihomo-γ-linolenic acid (DGLA), but to date it has not been isolated as a natural product. An inhibitor of ADP-induced platelet aggregation in humans with an IC|50|value of 320 ng/ml, about 1/10 as potent as

13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been found in the rat stomach. The measurement of 13,14-dihydro-15-keto PGF1α can be used as a marker of PGF1α production.

13,14-dihydro-15-keto Prostaglandin F1α (13,14-dihydro-15-keto PGF1α) is a metabolite of PGF1α that has been found in the rat stomach. The measurement of 13,14-dihydro-15-keto PGF1α can be used as a marker of PGF1α production.

13,14-dihydro-15-keto PGF|2α|isopropyl ester is a more lipid soluble derivative of 13,14-dihydro-15-keto PGF|2α|. There are no published reports on the biological activity of this compound.

13,14-dihydro-15-keto PGF|2α|isopropyl ester is a more lipid soluble derivative of 13,14-dihydro-15-keto PGF|2α|. There are no published reports on the biological activity of this compound.

Various biological properties exist for both PGJ2 and its metabolites such as inhibition of platelet aggregation, antitumor, and antiviral activity.1,2 It is the dehydration product of 13,14-dihydro-15-keto PGD2 and is a presumed metabolite of PGJ2

Various biological properties exist for both PGJ2 and its metabolites such as inhibition of platelet aggregation, antitumor, and antiviral activity.1,2 It is the dehydration product of 13,14-dihydro-15-keto PGD2 and is a presumed metabolite of PGJ2